BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15567423)

  • 1. The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801: possible implications for psychosis.
    Carter K; Dickerson J; Schoepp DD; Reilly M; Herring N; Williams J; Sallee FR; Sharp JW; Sharp FR
    Neuropharmacology; 2004 Dec; 47(8):1135-45. PubMed ID: 15567423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK-801) injures pyramidal neurons in rat retrosplenial cortex.
    Tomitaka S; Tomitaka M; Tolliver BK; Sharp FR
    Eur J Neurosci; 2000 Apr; 12(4):1420-30. PubMed ID: 10762370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of LY379268, a selective group II metabotropic glutamate receptor agonist, on dizocilpine-induced neuropathological changes in rat retrosplenial cortex.
    Okamura N; Hashimoto K; Shimizu E; Koike K; Ohgake S; Koizumi H; Kumakiri C; Komatsu N; Iyo M
    Brain Res; 2003 Nov; 992(1):114-9. PubMed ID: 14604779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mGluR
    Sokolenko E; Hudson MR; Nithianantharajah J; Jones NC
    J Psychopharmacol; 2019 Dec; 33(12):1588-1599. PubMed ID: 31580222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain.
    Di Liberto V; Bonomo A; Frinchi M; Belluardo N; Mudò G
    Neuroscience; 2010 Feb; 165(3):863-73. PubMed ID: 19909793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of glutamatergic and GABAergic transmission in MK-801-increased gamma band oscillation power in rat cortical electroencephalograms.
    Hiyoshi T; Kambe D; Karasawa J; Chaki S
    Neuroscience; 2014 Nov; 280():262-74. PubMed ID: 25220900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
    Cartmell J; Monn JA; Schoepp DD
    J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine A1 receptor agonists block the neuropathological changes in rat retrosplenial cortex after administration of the NMDA receptor antagonist dizocilpine.
    Okamura N; Hashimoto K; Shimizu E; Kumakiri C; Komatsu N; Iyo M
    Neuropsychopharmacology; 2004 Mar; 29(3):544-50. PubMed ID: 14603270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotics and a Src kinase inhibitor (PP1) prevent cortical injury produced by the psychomimetic, noncompetitive NMDA receptor antagonist MK-801.
    Dickerson J; Sharp FR
    Neuropsychopharmacology; 2006 Jul; 31(7):1420-30. PubMed ID: 16123741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective.
    Caraci F; Molinaro G; Battaglia G; Giuffrida ML; Riozzi B; Traficante A; Bruno V; Cannella M; Merlo S; Wang X; Heinz BA; Nisenbaum ES; Britton TC; Drago F; Sortino MA; Copani A; Nicoletti F
    Mol Pharmacol; 2011 Mar; 79(3):618-26. PubMed ID: 21159998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of the metabotropic glutamate (mGlu) 2 receptor attenuates the MK-801-induced increase in the immobility time in the forced swimming test in rats.
    Kawaura K; Karasawa J; Hikichi H
    Pharmacol Rep; 2016 Feb; 68(1):80-4. PubMed ID: 26721357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal injury produced by NMDA antagonists can be detected using heat shock proteins and can be blocked with antipsychotics.
    Sharp FR; Butman M; Aardalen K; Nickolenko J; Nakki R; Massa SM; Swanson RA; Sagar SM
    Psychopharmacol Bull; 1994; 30(4):555-60. PubMed ID: 7770620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats.
    Pitsikas N; Markou A
    Neuropharmacology; 2014 Oct; 85():27-35. PubMed ID: 24859609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
    Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
    J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
    Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
    Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing.
    Jones CK; Eberle EL; Peters SC; Monn JA; Shannon HE
    Neuropharmacology; 2005; 49 Suppl 1():206-18. PubMed ID: 15998527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis.
    de Bartolomeis A; Sarappa C; Buonaguro EF; Marmo F; Eramo A; Tomasetti C; Iasevoli F
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():1-12. PubMed ID: 23800465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice.
    Molinaro G; Traficante A; Riozzi B; Di Menna L; Curto M; Pallottino S; Nicoletti F; Bruno V; Battaglia G
    Mol Pharmacol; 2009 Aug; 76(2):379-87. PubMed ID: 19439499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabotropic glutamate receptors regulate cortical gamma hyperactivities elicited by ketamine in rats.
    Hiyoshi T; Hikichi H; Karasawa J; Chaki S
    Neurosci Lett; 2014 May; 567():30-4. PubMed ID: 24680852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex.
    Fix AS; Horn JW; Wightman KA; Johnson CA; Long GG; Storts RW; Farber N; Wozniak DF; Olney JW
    Exp Neurol; 1993 Oct; 123(2):204-15. PubMed ID: 8405286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.